Business & Financial News, Breaking US & International News | Reuters
United States

Biotechnology & Medical Research

Page 1

Immunomedics says appoints Garone as new CFO

Tuesday, 21 Jun 2016 08:00am EDT

Immunomedics Inc : Immunomedics appoints Michael R. Garone as new chief financial officer . Immunomedics Inc says Garone replaces Peter P. Pfreundschuh . Immunomedics Inc says Peter P. Pfreundschuh will serve as a consultant to company for next few months to ensure a smooth transition .Immunomedics appoints Michael R. Garone as new chief financial officer.

Zosano Pharma says appointed Georgia Erbez as interim CFO

Friday, 17 Jun 2016 05:00pm EDT

Zosano Pharma Corp : Appointed Georgia Erbez as interim chief financial officer of company .Erbez will be assuming duties of Winnie Tso who is currently on a temporary medical leave of absence.

Critical Outcome Tech appoints Alison Silva as new president

Wednesday, 15 Jun 2016 09:15am EDT

Critical Outcome Technologies Inc : Appointment of alison silva as new president of company effective july 5, 2016 .Critical outcome technologies appoints experienced industry executive as new president.

Anteo Diagnostics announces commencement of new CEO

Monday, 13 Jun 2016 10:24pm EDT

Anteo Diagnostics Ltd : Commencement of new CEO . Announce the commencement of jef vangenechten as group chief executive officer .

Veracyte CFO Shelly Guyer resigns

Monday, 13 Jun 2016 04:05pm EDT

Veracyte Inc : Veracyte announces resignation of its chief financial officer . Says CFO Shelly Guyer resigned .Initiated a national search for a new chief financial officer.

Adverum Biotechnologies appoints Leone Patterson as CFO

Monday, 13 Jun 2016 07:16am EDT

Adverum Biotechnologies Inc : Leone Patterson has been appointed as company's chief financial officer - SEC filing . Patterson will also assume duties of company's principal financial officer. .Patterson served as chief financial officer of diadexus, inc. From march 2015 to june 2016.

Novabay Pharmaceuticals appoints Mark Sieczkarek president and CEO

Monday, 13 Jun 2016 06:50am EDT

Novabay Pharmaceuticals Inc : On track to achieve target of positive cash flow from operations by end of 2016 & accelerated revenue growth beyond . Mark Sieczkarek has served as co's interim president and ceo since november 2015 .Novabay pharmaceuticals appoints Mark M. Sieczkarek president and chief executive officer.

Osiris Therapeutics says names David Dresner interim CEO

Friday, 10 Jun 2016 04:08pm EDT

Osiris Therapeutics Inc : Says it has appointed David Dresner as interim president and chief executive officer .Dresner is expected to serve in that capacity until board completes its search for a permanent CEO.

Bio Blast Pharma updates corporate plans

Thursday, 9 Jun 2016 06:00am EDT

Bio Blast Pharma Ltd : Says Fredric Price, executive chairman, will lead company's day-to-day operational efforts . Intends to enroll more than 70 patients in phase 2B clinical trial at up to 15 sites in United States and Canada . Plans to initiate a phase 2B trial with trehalose IV solution in OPMD during second half of 2016 . Colin Foster, Bioblast's president and CEO, will be leaving his operational position . Made decision to streamline company expenditures and downsize management team . Up to 8 employees have left or will be leaving co, including chief commercial officer, chief corporate development officer, CFO .Bio Blast Pharma updates corporate plans.

NanoenTek announces change of CEO

Wednesday, 8 Jun 2016 02:00am EDT

NanoenTek,Inc. <039860.KQ> :Says is appoints Kim Myeong Rip as chief executive officer of the company, to replace Park Jin Hyeong, who has resigned from this position, effective June 8.


  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider : Thomson Reuters StreetEvents
Provider : Thomson Reuters StreetEvents
Provider : Edison Investment Research
Provider : Thomson Reuters StreetEvents
Provider : Edison Investment Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.